When the FDA first approved testosterone replacement therapy (TRT) drugs decades ago, they approved them only for medically related low testosterone, or “hypogonadism,” a condition in which testosterone levels go down because of a medical issue, like a pituitary gland malfunction or testicle problem
On June 14, 2016, the Food and Drug Administration (FDA) released another safety communication concerning the type 2 diabetes medication, Invokana (canagliflozin). It warned physicians and patients that Invokana and other similar medications (like Farxiga and Xigduo XR) can increase the risk of seri
According to a new study, heartburn drugs like Nexium and Prilosec may increase risk of osteoporosis—a disease in which the bones become weak and brittle and prone to fracture. A study in the journal of International Journal of Rheumatic Diseases, has raised more concerns about…
A number of recent studies have linked proton pump inhibitors (PPIs) like Nexium and Prilosec with an increased risk of chronic kidney disease. In 2010, the FDA warned that the medications could increase risk of bone fracture, and other studies have also connected them to…
Pregnant women are understandably cautious when it comes to taking medications. They recognize that some may be harmful to an unborn child. However, most moms also believe that if a product doesn’t warn that it may create a risk of birth defects, that the manufacturer…
A Kentucky woman has filed an Invokana lawsuit in the District of New Jersey. She says that after taking the type 2 diabetes drug Invokana (canagliflozin), she suffered serious injuries. She blames manufacturers Janssen Pharmaceuticals and parent company Johnson & Johnson, and seeks in excess…
A number of scientific studies have come out over the past year linking proton pump inhibitors (PPIs) like Nexium and Prilosec to a significant increased risk of kidney impairment and kidney failure. One that was released in February 2016, for example, reported that those who…
Another lawsuit has joined the Xarelto MDL in the Eastern District of Louisiana. The consolidated Xarelto litigation was centralized in December 2014, for cases in which plaintiffs claim they were injured after taking the anticoagulant Xarelto (rivaroxaban). There are currently over 5,000 cases pend
New research has found that proton pump inhibitors (PPIs) like Nexium, Prilosec, and Aciphex, may increase the risk of kidney impairment and kidney failure. The most recent study on the issue, published in April 2016, found similar results, and cautions that long-term use of these…
The FDA has released a new warning concerning the type 2 diabetes drug, Invokana (canagliflozin). A year ago, they released a previous safety communication warning doctors and patients that Invokana could increase risk of diabetic ketoacidosis (DKA), a serious condition in which the blood becomes…
The FDA has recently announced that new warnings will be added to the labels of both Onglyza (saxagliptin) and Nesina (alogliptin), cautioning that they may increase the risk for heart failure, especially in patients who already have kidney disease or cardiovascular disease. Both of these…
In early 2014, the FDA warned about study results that suggested the type 2 diabetes drug Onglyza could be linked to the risk of heart failure. In April 2015, the FDA scheduled an advisory panel meeting of the Endocrinologic and Metabolic Drugs Advisory Committee to…